Metis Global Partners’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
10,829
+1,858
+21% +$196K 0.02% 440
2026
Q1
$1.01M Hold
8,971
0.02% 437
2025
Q4
$989K Buy
8,971
+1,544
+21% +$174K 0.02% 460
2025
Q3
$907K Buy
7,427
+1,888
+34% +$243K 0.02% 497
2025
Q2
$751K Buy
5,539
+1,214
+28% +$164K 0.02% 518
2025
Q1
$585K Buy
4,325
+336
+8% +$44.4K 0.02% 564
2024
Q4
$549K Buy
3,989
+136
+4% +$19.1K 0.02% 560
2024
Q3
$530K Buy
3,853
+1,035
+37% +$132K 0.02% 562
2024
Q2
$323K Buy
2,818
+481
+21% +$55.5K 0.01% 642
2024
Q1
$273K Sell
2,337
-38
-2% -$4.28K 0.01% 670
2023
Q4
$258K Buy
+2,375
New +$238K 0.01% 669

Other funds holding INGR

Metis Global Partners's INGR Position: Q2 2026 in Review

Metis Global Partners increased its Ingredion (INGR) stake by 21% in Q2 2026, buying an estimated $196K and bringing the position to 10,829 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #440.

Metis Global Partners first reported a position in INGR in Q4 2023 and has held it in 11 quarters since. 608 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

  • Metis Global Partners held 10,829 shares of Ingredion worth $1.03M as of Q2 2026.
  • Metis Global Partners bought 1,858 Ingredion shares in Q2 2026, an estimated $196K.
  • Ingredion made up 0.02% of Metis Global Partners's portfolio in Q2 2026, its #440 holding.
  • Metis Global Partners first reported a position in Ingredion in Q4 2023 and has held it in 11 quarters since.
  • 608 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.